FY2024 Earnings Estimate for SIGA Issued By Edison Inv. Res

SIGA Technologies, Inc. (NASDAQ:SIGA) – Equities researchers at Edison Inv. Res issued their FY2024 earnings per share (EPS) estimates for shares of SIGA Technologies in a research report issued to clients and investors on Monday, November 18th. Edison Inv. Res analyst J. Prakash forecasts that the company will post earnings per share of $1.04 for the year. Edison Inv. Res also issued estimates for SIGA Technologies’ FY2025 earnings at $1.25 EPS.

SIGA Technologies Price Performance

SIGA opened at $6.27 on Thursday. SIGA Technologies has a fifty-two week low of $4.26 and a fifty-two week high of $12.83. The business has a 50-day moving average of $7.06 and a 200-day moving average of $7.90. The company has a market capitalization of $447.68 million, a PE ratio of 5.23 and a beta of 0.89.

SIGA Technologies (NASDAQ:SIGA) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.02 earnings per share for the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. The company had revenue of $10.01 million during the quarter.

Institutional Investors Weigh In On SIGA Technologies

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in shares of SIGA Technologies by 1.9% in the 1st quarter. Vanguard Group Inc. now owns 2,283,612 shares of the company’s stock valued at $19,548,000 after acquiring an additional 41,515 shares in the last quarter. CANADA LIFE ASSURANCE Co increased its position in SIGA Technologies by 996.5% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 24,836 shares of the company’s stock worth $212,000 after buying an additional 22,571 shares during the period. EntryPoint Capital LLC bought a new position in SIGA Technologies in the 1st quarter worth approximately $111,000. Lazard Asset Management LLC bought a new position in SIGA Technologies in the 1st quarter worth approximately $105,000. Finally, Price T Rowe Associates Inc. MD increased its position in SIGA Technologies by 8.2% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 29,180 shares of the company’s stock worth $250,000 after buying an additional 2,218 shares during the period. 55.40% of the stock is owned by hedge funds and other institutional investors.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.